Corvus Pharmaceuticals (CRVS) Q3 2024 Earnings
CRVS·Reported November 12, 2024·After market close
Diluted EPS came in at $-0.11.
Diluted EPS
$-0.11met estimate
Consensus: $-0.11
Financial Snapshot
Trailing eight quarters through Q3 2024
Q3 2024 Earnings FAQ
Common questions about Corvus Pharmaceuticals's Q3 2024 earnings report.
Corvus Pharmaceuticals (CRVS) reported Q3 2024 earnings on November 12, 2024 after market close.
Corvus Pharmaceuticals reported diluted EPS of $-0.11 for Q3 2024.
EPS beat the consensus estimate of $-0.11 by $0.00.
You can read the 10-Q periodic report (0001558370-24-015306) directly on SEC EDGAR. The filing index links above go to sec.gov.